{"nct_id":"NCT01592370","title":"An Investigational Immuno-Therapy Study to Determine the Safety and Effectiveness of Nivolumab and Daratumumab in Patients With Multiple Myeloma","status":"COMPLETED","status_verified_date":"2024-08","start_date":"2012-08-02","start_date_type":"ACTUAL","primary_completion_date":"2020-09-25","primary_completion_date_type":"ACTUAL","completion_date":"2024-07-09","completion_date_type":"ACTUAL","phases":["PHASE1","PHASE2"],"tickers":["BMY"]}